High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$1.7M
$1,683,189
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| KNSA |
Kiniksa Pharmaceuticals International, plc
|
Director
Other
|
2026-02-12 | $41,614 | M | Form 4 |
|
KNSA
S
Kiniksa Pharmaceuticals International, plc
Quart Barry D
• Director
10b5-1 SellΔOwn -17.7%
2026-02-12
$121,050
|
||||||
| KNSA |
Kiniksa Pharmaceuticals International, plc
|
Director
10b5-1 SellΔOwn -17.7%
|
2026-02-12 | $121,050 | S | Form 4 |
|
KNSA
S
Kiniksa Pharmaceuticals International, plc
Quart Barry D
• Director
10b5-1 Sell
2026-02-10
$4,950
|
||||||
| KNSA |
Kiniksa Pharmaceuticals International, plc
|
Director
10b5-1 Sell
|
2026-02-10 | $4,950 | S | Form 4 |
| KNSA |
Kiniksa Pharmaceuticals International, plc
|
Director
Other
|
2026-02-10 | $1,702 | M | Form 4 |
|
KNSA
S
Kiniksa Pharmaceuticals International, plc
Quart Barry D
• Director
10b5-1 SellΔOwn -17.2%
2026-02-04
$117,142
|
||||||
| KNSA |
Kiniksa Pharmaceuticals International, plc
|
Director
10b5-1 SellΔOwn -17.2%
|
2026-02-04 | $117,142 | S | Form 4 |
| KNSA |
Kiniksa Pharmaceuticals International, plc
|
Director
Other
|
2026-02-04 | $40,253 | M | Form 4 |
|
KNSA
S
Kiniksa Pharmaceuticals International, plc
Quart Barry D
• Director
10b5-1 SellΔOwn -50.0%
2026-02-03
$567,143
|
||||||
| KNSA |
Kiniksa Pharmaceuticals International, plc
|
Director
10b5-1 SellΔOwn -50.0%
|
2026-02-03 | $567,143 | S | Form 4 |
|
KNSA
M
Kiniksa Pharmaceuticals International, plc
Quart Barry D
• Director
Other
2026-02-03
$193,808
|
||||||
| KNSA |
Kiniksa Pharmaceuticals International, plc
|
Director
Other
|
2026-02-03 | $193,808 | M | Form 4 |
|
KNSA
S
Kiniksa Pharmaceuticals International, plc
Quart Barry D
• Director
10b5-1 Sell
2026-02-02
$37,350
|
||||||
| KNSA |
Kiniksa Pharmaceuticals International, plc
|
Director
10b5-1 Sell
|
2026-02-02 | $37,350 | S | Form 4 |
| KNSA |
Kiniksa Pharmaceuticals International, plc
|
Director
Other
|
2026-02-02 | $12,840 | M | Form 4 |
|
KNSA
M
Kiniksa Pharmaceuticals International, plc
Quart Barry D
• Director
Other
2025-12-15
$208,536
|
||||||
| KNSA |
Kiniksa Pharmaceuticals International, plc
|
Director
Other
|
2025-12-15 | $208,536 | M | Form 4 |
|
KNSA
M
Kiniksa Pharmaceuticals International, plc
Quart Barry D
• Director
Equity Compensation
2025-12-15
$0
|
||||||
| KNSA |
Kiniksa Pharmaceuticals International, plc
|
Director
Equity Compensation
|
2025-12-15 | $0 | M | Form 4 |
|
KNSA
S
Kiniksa Pharmaceuticals International, plc
Quart Barry D
• Director
10b5-1 SellΔOwn -61.6%
2025-12-15
$835,555
|
||||||
| KNSA |
Kiniksa Pharmaceuticals International, plc
|
Director
10b5-1 SellΔOwn -61.6%
|
2025-12-15 | $835,555 | S | Form 4 |